#USA #Atlanta #clinical study #CAST #LevaLap

CAST's Clinical Study Manuscript Accepted by Leading Surgical Journal

Acceptance of CAST Clinical Study Manuscript

ATLANTA, May 15, 2025 /PRNewswire/ -- Core Access Surgical Technologies, Inc. (CAST) has announced the acceptance of its latest clinical study manuscript for publication in the prestigious Journal of the Society of Laparoscopic and Robotic Surgeons (JSLS). This journal is renowned for its focus on minimally invasive surgery and robotic innovations. The manuscript showcases the LevaLap™ 1.0's growing adoption in operating rooms across the globe, asserting its clinical effectiveness and added value, thus fostering interest among next-generation surgeons, advanced practitioners, key opinion leaders, and robotic surgery specialists. The clinical study's findings are now available on PubMed, providing a valuable resource for medical professionals.

Benefits of LevaLap™ 1.0 in Laparoscopic Access

The study's results clearly indicate that the LevaLap™ 1.0 device offers significant advantages for even experienced surgeons, such as enhanced ease of use, greater control, improved speed, and increased safety when accessing the abdomen using the Veress needle in minimally invasive procedures. Dr. Ricardo Azziz, the corresponding author, highlighted that the value of this tool is amplified by the widespread number of surgeons performing such operations globally, regardless of their experience level.

Acknowledgment of JSLS

CAST expresses its gratitude to the Journal of the Society of Laparoscopic Surgeons for providing a reputable platform to disseminate these findings. The JSLS plays a vital role in advancing minimally invasive surgery by promoting the sharing of scientific knowledge and clinical innovations. CAST feels honored to be part of a global initiative that strives to enhance surgical outcomes through rigorous research and collaboration.

Multicenter and International Study

"We are proud of this significant advancement towards the global standardization of the Veress needle access technique in laparoscopic surgery utilizing CAST's LevaLap™ 1.0 device," stated Thomas A. Gordy, Chairman and CEO of CAST. The study was multicenter and international, involving surgeons with diverse backgrounds and access techniques. The results validate LevaLap’s adaptability, safety, efficacy, and user-friendliness. This milestone underscores the success of the LevaLap™ 1.0 access approach in improving surgical outcomes and standardizing laparoscopic access.

About CAST Surgical

CAST is a US-based, globally active medical technology company that designs, develops, manufactures, and distributes access instruments for laparoscopic surgery. Its aim is to enable precision, minimize risks, and standardize efficient access. CAST is committed to providing the medical community with superior and innovative solutions representing unique clinical and economic value. More information can be found at www.castsurgical.com.

About JSLS

The Journal of the Society of Laparoscopic and Robotic Surgeons (JSLS) is a leading peer-reviewed publication dedicated to minimally invasive surgery. It consistently ranks among the top 1% of over 16,000 scientific journals on PubMed Central, showcasing a high readership and significant engagement.